Compounded Tirzepatide: Cost, Safety & How It Works

What Is Compounded Tirzepatide?

Tirzepatide is the active ingredient in the brand-name medications Mounjaro® (for type 2 diabetes) and Zepbound® (for chronic weight management), both manufactured by Eli Lilly. It is a dual GIP/GLP-1 receptor agonist — a "twincretin" that has produced the greatest average weight loss of any non-surgical treatment studied to date.

Compounded tirzepatide is a customized preparation of the medication made by a state-licensed compounding pharmacy in response to a valid prescription from a licensed provider. It is different from FDA-approved branded products such as Zepbound® and Mounjaro® and has not been evaluated by the FDA for safety, efficacy, or quality. Formulation, strength, inactive ingredients, and clinical effects may differ from the FDA-approved branded versions.

Why Does Compounded Tirzepatide Exist?

When a medication appears on the FDA's drug shortage list, federal law permits state-licensed compounding pharmacies to prepare customized versions of it. Tirzepatide spent extended periods in shortage as demand surged, opening the door for compounded access. For the millions of Americans without insurance coverage for weight-loss medications, compounded tirzepatide became a primary access point.

How Effective Is Tirzepatide?

The SURMOUNT-1 trial (published in the New England Journal of Medicine, 2022) studied tirzepatide for weight management in adults with obesity:

• Participants on the 15 mg dose lost an average of 22.5% of body weight over 72 weeks.
• 56% of participants on the highest dose lost at least 20% of their body weight.
• For a 220-lb person, that translates to roughly 48 lbs of average weight loss. Individual results may vary.

For a head-to-head look at how it stacks up against semaglutide, see our semaglutide vs tirzepatide comparison.

How Does Tirzepatide Work?

Tirzepatide activates two gut-hormone receptors at once:

GLP-1 Receptor

Reduces appetite, slows gastric emptying, and increases feelings of fullness — the same pathway semaglutide targets.

GIP Receptor

Glucose-dependent insulinotropic polypeptide is involved in fat metabolism and energy balance. This second mechanism is thought to explain why tirzepatide produces greater average weight loss than single-pathway GLP-1 medications.

Cost: What to Know

Brand-name Zepbound® costs roughly $1,050-$1,400 per month without insurance. Compounded tirzepatide through a licensed telehealth provider typically costs a fraction of that, and AvataCore offers introductory pricing as low as $149 for your first month. Pricing varies by program and dose — see AvataCore pricing → for current plans. For a full breakdown, read our tirzepatide cost guide.

Quality and Safety: What to Look For

Not all compounding pharmacies are equal. Reputable telehealth providers partner with state-licensed compounding pharmacies that prepare medications only in response to valid prescriptions, source active pharmaceutical ingredients from reputable suppliers, and conduct independent potency and sterility testing with certificates of analysis (COAs) available on request.

Questions to Ask Before You Start

• Is the pharmacy licensed by its state board of pharmacy?
• Is the active pharmaceutical ingredient sourced from a reputable supplier?
• Are certificates of analysis (COAs) available for each batch?
• Is the medication produced under sterile conditions?
• Will a licensed provider review my health history and oversee my treatment?

Who Is a Candidate?

Tirzepatide is generally considered for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. It is not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2, or those who are pregnant or breastfeeding. A licensed provider will determine whether it is appropriate for you. Learn more about GLP-1 eligibility.

Side Effects

The most common side effects are gastrointestinal — nausea, diarrhea, constipation, and stomach discomfort — particularly during dose escalation. These are usually mild-to-moderate and improve over time. See our full guide to GLP-1 side effects and how to manage them.